OBJECTIVE: To describe the trends in the prevalence of type 2 diabetes (T2D), and other cardiovascular risk factors in three national health surveys (1993, 2000 and 2006). MATERIALS AND METHODS: The databases of three surveys: ENEC 1993, ENSA 2000 and ENSANUT 2006 were gathered. Calculations of published data were reprocessed to do appropriate adjustments to assure comparability among surveys. RESULTS: From 1993 to 2006 the prevalence of type 2 diabetes (6.7-14.4%), metabolic syndrome (26.6-36.8%), hypertension (23.8-30.7%), hypercholesterolemia (27-43.6%), and high LDL-cholesterol (31.6-46%) increased rapidly. The prevalence of low HDL cholesterol was very high (60.5-63%) in all surveys and remained remarkably unchanged among surveys. CONCLUSIONS: This increasing trends for the prevalence of T2D and cardiovascular risk factors predicts larger increments in the near future for T2D and cardiovascular morbidity and mortality. Intensification of the preventive and remedy strategies is mandatory in order curve the foreseen dramatic increment in the disease burden.
OBJECTIVE: To describe the trends in the prevalence of type 2 diabetes (T2D), and other cardiovascular risk factors in three national health surveys (1993, 2000 and 2006). MATERIALS AND METHODS: The databases of three surveys: ENEC 1993, ENSA 2000 and ENSANUT 2006 were gathered. Calculations of published data were reprocessed to do appropriate adjustments to assure comparability among surveys. RESULTS: From 1993 to 2006 the prevalence of type 2 diabetes (6.7-14.4%), metabolic syndrome (26.6-36.8%), hypertension (23.8-30.7%), hypercholesterolemia (27-43.6%), and high LDL-cholesterol (31.6-46%) increased rapidly. The prevalence of low HDL cholesterol was very high (60.5-63%) in all surveys and remained remarkably unchanged among surveys. CONCLUSIONS: This increasing trends for the prevalence of T2D and cardiovascular risk factors predicts larger increments in the near future for T2D and cardiovascular morbidity and mortality. Intensification of the preventive and remedy strategies is mandatory in order curve the foreseen dramatic increment in the disease burden.
Authors: M A Granados-Silvestre; M G Ortiz-López; J Granados; S Canizales-Quinteros; Rosenda I Peñaloza-Espinosa; C Lechuga; V Acuña-Alonzo; K Sánchez-Pozos; M Menjivar Journal: Mol Genet Genomics Date: 2017-07-07 Impact factor: 3.291
Authors: Luis A Rodríguez; Simón Barquera; Carlos A Aguilar-Salinas; Jaime Sepúlveda-Amor; Luz María Sánchez-Romero; Edgar Denova-Gutiérrez; Nydia Balderas; Lizbeth Moreno-Loaeza; Margaret A Handley; Sanjay Basu; Oliva López-Arellano; Alberto Gallardo-Hernández; Dean Schillinger Journal: Contemp Clin Trials Date: 2020-06-21 Impact factor: 2.226
Authors: Ricardo Pérez-Cuevas; Svetlana V Doubova; Magdalena Suarez-Ortega; Michael Law; Aakanksha H Pande; Jorge Escobedo; Francisco Espinosa-Larrañaga; Dennis Ross-Degnan; Anita K Wagner Journal: BMC Med Inform Decis Mak Date: 2012-06-06 Impact factor: 2.796
Authors: Daniel Cuevas Ramos; Roopa Mehta; Julieta De La Luz Castro; Rutila Castañeda Limones; Ernesto García Rubí; Carlos A Aguilar-Salinas Journal: Diabetes Metab Syndr Obes Date: 2011-03-28 Impact factor: 3.168
Authors: Paul F Jacques; Aedin Cassidy; Gail Rogers; Julia J Peterson; James B Meigs; Johanna T Dwyer Journal: J Nutr Date: 2013-07-31 Impact factor: 4.798